We are live on ! Find out more
LMAT icon

LeMaitre Vascular

283 hedge funds and large institutions have $1.76B invested in LeMaitre Vascular in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 116 increasing their positions, 98 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 98

0.09% less ownership

Funds ownership: 93.71%93.62% (-0.09%)

1% less capital invested

Capital invested by funds: $1.77B → $1.76B (-$16.9M)

3% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 29

2% less funds holding

Funds holding: 288283 (-5)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
283
Holders Change
-5
Holders Change %
-1.74%
% of All Funds
3.73%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
28
Increased
116
Reduced
98
Closed
29
Calls
$58K
Puts
Net Calls
+$58K
Net Calls Change
+$67K
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$15.7M -$6.12M -73,174 -28%
DDC
27
DF Dent & Co
Maryland
$15.6M +$251K +3,001 +2%
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$14.4M +$954K +11,416 +7%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$14.2M -$585 -7 -0%
SCA
30
Summit Creek Advisors
Minnesota
$14M -$611K -7,308 -4%
KCM
31
Kennedy Capital Management
Missouri
$13.6M -$257K -3,072 -2%
Renaissance Technologies
32
Renaissance Technologies
New York
$13.2M +$368K +4,400 +3%
JP Morgan Chase
33
JP Morgan Chase
New York
$12.4M -$1.98M -23,748 -14%
Comerica Bank
34
Comerica Bank
Texas
$12M +$13.4K +160 +0.1%
AIC
35
AWM Investment Company
New York
$10.8M -$1.25M -15,000 -10%
BG
36
Bahl & Gaynor
Ohio
$10.2M +$81K +969 +0.8%
Bank of America
37
Bank of America
North Carolina
$9.57M +$2.25M +26,966 +31%
OAM
38
Oberweis Asset Management
Illinois
$9.52M +$1.05M +12,601 +12%
Principal Financial Group
39
Principal Financial Group
Iowa
$9.38M +$85.7K +1,025 +0.9%
CIC
40
Crawford Investment Counsel
Georgia
$9.22M +$168K +2,010 +2%
Marshall Wace
41
Marshall Wace
United Kingdom
$9.18M -$1.29M -15,466 -12%
SEI Investments
42
SEI Investments
Pennsylvania
$8.5M +$392K +4,685 +5%
CWM
43
Congress Wealth Management
Massachusetts
$7.87M -$208K -2,483 -3%
SBH
44
Segall Bryant & Hamill
Illinois
$6.88M +$529K +6,335 +8%
ProShare Advisors
45
ProShare Advisors
Maryland
$6.57M -$1.06M -12,721 -14%
GPGA
46
Grandeur Peak Global Advisors
Utah
$6.27M +$6.31M +75,551 New
Victory Capital Management
47
Victory Capital Management
Texas
$6.23M -$405K -4,846 -6%
BCC
48
Bridge City Capital
Oregon
$6.11M -$68.9K -824 -1%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$6.08M +$92.3K +1,105 +2%
Public Sector Pension Investment Board (PSP Investments)
50
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$5.82M +$434K +5,190 +8%

LMAT Hedge Fund Activity: Q2 2025 in Review

283 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2025, worth a combined $1.76B — down 0.95% from $1.77B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of LMAT and 28 opened new positions — a net loss of 1 holder — while 98 trimmed existing stakes and 116 added.

The largest buyer was First Trust Advisors, adding an estimated $17.7M. The largest seller was BlackRock, cutting an estimated $34.3M.

  • 283 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2025, down from 288 in Q1 2025.
  • Funds reported $1.76B of LeMaitre Vascular stock for Q2 2025, down 0.95% quarter-over-quarter.
  • 28 funds opened new LeMaitre Vascular positions in Q2 2025 and 29 closed out, a net change of -1 holder.
  • The largest LeMaitre Vascular buyer in Q2 2025 was First Trust Advisors, an estimated $17.7M added.
  • The largest LeMaitre Vascular seller in Q2 2025 was BlackRock, an estimated $34.3M sold.

Based on aggregated 13F filings for Q2 2025.